Mall PA
NAD+ NOT FOR HUMANS CHECK BEFORE YOU COMPETE
File 01 · naturally occurring coenzyme (a dinucleotide, not a peptide)

NAD+ (injectable)

Also called: nicotinamide adenine dinucleotide, NAD, beta-NAD

Substance OK. IV over 100 mL is bannedVery limited

NAD+ is a coenzyme found in every living cell, where it carries electrons in energy metabolism and fuels enzymes such as sirtuins and PARPs. 'Research NAD+' sold in vials is the molecule itself; it is different from oral NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which are sold as dietary supplements and are converted to NAD+ inside the body.

Why the gym talks about it

NAD+ has a longevity and 'cellular energy' reputation, helped by the observation that NAD+ levels fall with age, and IV or injectable NAD+ is sold through wellness clinics. In gym culture it gets framed as a recovery and energy tool, mostly on anecdote.

What the research actually found

  • review of animal and human dataNAD+ levels decline with age in several rodent and some human tissues, and restoring NAD+ improved multiple age-related measures in animal models. Most of the strongest evidence is from rodents. Source
  • small human pilot studyIn a pilot of 8 healthy men given a slow 6-hour IV NAD+ infusion (plus 3 saline controls), plasma NAD+ did not rise for the first 2 hours, then rose about 4-fold by the end. No adverse events were seen in that study. Source
  • small retrospective human studyA 2026 retrospective chart review from a wellness clinic (6 IV NAD+, 8 IV NR recipients) found that all six NAD+ recipients reported moderate to severe cramping, nausea, diarrhea, vomiting or raised heart rate during infusion, which ran longer than NR infusions. Source
  • small randomized human trial (oral NR)Oral precursors (not injected NAD+) have the most controlled human data: in a 6-week randomized crossover trial in healthy middle-aged and older adults, oral nicotinamide riboside raised blood NAD+ and was well tolerated. Source
  • small randomized human trial (oral NMN)In a 10-week randomized trial in women with prediabetes and overweight or obesity, oral NMN increased muscle insulin sensitivity. Results from oral precursors do not automatically apply to injected NAD+. Source

Human evidence: very limited. For injected or IV NAD+ the human data are small pilots and chart reviews focused on blood levels and tolerability, not performance or recovery outcomes; oral NR/NMN have more (still small) randomized trials.

Tested lifters

Not prohibited as a substance. Method M2.2 applies: IV infusions and/or injections of more than 100 mL per 12-hour period are prohibited at all times unless received during hospital treatment, surgery or clinical diagnostic investigations.

Low for the substance itself, but a typical clinic IV NAD+ drip is often well over 100 mL, which can be a violation by method without a TUE. USA Powerlifting tests against the WADA list (https://www.usapowerlifting.com/tue/); other tested federations generally use WADA-style lists.

FDA status

Not an FDA-approved drug. NAD is listed in Category 1 of FDA's interim 503A bulk drug substances list (the list FDA updated May 14, 2026), which means licensed 503A compounding pharmacies may compound it under FDA's interim policy for patient-specific prescriptions. Oral NMN: FDA confirmed on Sept 29, 2025 that NMN is lawful in dietary supplements. NR is sold as a supplement.

As of 2026-10-01.

Known and theoretical risks

  • IV infusions commonly cause nausea, abdominal cramping, chest or throat discomfort and a raised heart rate, especially at faster infusion rates. Source
  • Long-term safety of repeated high-dose NAD+ injections has not been studied in controlled trials. Source
  • Gray-market vials sold 'for research only' are not made or inspected as drugs; sterility and content are only as good as the seller's own testing. Source

Quick answers

Is NAD+ (injectable) banned for drug-tested lifters?

Not prohibited as a substance. Method M2.2 applies: IV infusions and/or injections of more than 100 mL per 12-hour period are prohibited at all times unless received during hospital treatment, surgery or clinical diagnostic investigations. Low for the substance itself, but a typical clinic IV NAD+ drip is often well over 100 mL, which can be a violation by method without a TUE. USA Powerlifting tests against the WADA list (https://www.usapowerlifting.com/tue/); other tested federations generally use WADA-style lists.

Is NAD+ (injectable) FDA approved?

Not an FDA-approved drug. NAD is listed in Category 1 of FDA's interim 503A bulk drug substances list (the list FDA updated May 14, 2026), which means licensed 503A compounding pharmacies may compound it under FDA's interim policy for patient-specific prescriptions. Oral NMN: FDA confirmed on Sept 29, 2025 that NMN is lawful in dietary supplements. NR is sold as a supplement.

How strong is the human evidence for NAD+ (injectable)?

Very limited. For injected or IV NAD+ the human data are small pilots and chart reviews focused on blood levels and tolerability, not performance or recovery outcomes; oral NR/NMN have more (still small) randomized trials.

Sources

Research-use-only information file. Nothing here is medical advice or instructions for use. Not evaluated by the FDA. Talk to your doctor.

More files

Back to the basement